Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

SBAR II: Application of SBAR

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

Oral Hypoglycemic Agents: Glinides

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improvements in Glycemic Control and Depressive Symptoms Among Adults With Type 2 Diabetes: Retrospective Study.

JMIR formative research·2023

Same author

User engagement with a popular food brand before, during and after a multi-day interactive marketing campaign on a popular live streaming platform.

Public health nutrition·2023

Same author

Improvements in Depression Outcomes Following a Digital Cognitive Behavioral Therapy Intervention in a Polychronic Population: Retrospective Study.

JMIR formative research·2022

Same author

2022 National Standards for Diabetes Self-Management Education and Support.

Diabetes spectrum : a publication of the American Diabetes Association·2022

Same author

2022 National Standards for Diabetes Self-Management Education and Support.

The science of diabetes self-management and care·2022

Same author

2022 National Standards for Diabetes Self-Management Education and Support.

Diabetes care·2022

Search research articles

Related Experiment Video

Updated: Aug 18, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Changes in Glycemic Control Following Use of a Spanish-Language, Culturally Adapted Diabetes Program: Retrospective

Caitlyn Edwards¹, Elisa Orellana¹, Kelly Rawlings¹

¹Vida Health, San Francisco, CA, United States.

JMIR Formative Research

|December 8, 2022

Summary

A culturally adapted mHealth diabetes program significantly improved glycemic control in Spanish-speaking adults. Higher engagement with the program led to greater reductions in hemoglobin A1c (HbA1c).

Keywords:

HbA1c Spanish app-based diabetes diabetes intervention digital health digital health intervention glycemic improvements health application health coaching health education health management localization mhealth mobile health nutrition patient education type 2 diabetes

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

Related Experiment Videos

Last Updated: Aug 18, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

Area of Science:

Digital health interventions
Diabetes self-management
Health equity

Background:

Underserved medical communities face barriers to diabetes care.
Culturally relevant interventions are needed for diverse populations.
Mobile health (mHealth) offers potential solutions for diabetes management.

Purpose of the Study:

To evaluate a novel, culturally adapted, Spanish-language mHealth diabetes program.
To assess the program's impact on glycemic control (HbA1c).
To examine the relationship between program engagement and glycemic control outcomes.

Main Methods:

The Vida Health Diabetes Management Program was culturally localized into Spanish.
182 Spanish-speaking adults with diabetes used the app-based program.
Changes in hemoglobin A1c (HbA1c) were measured before and after program use.

Main Results:

A significant decrease in HbA1c of -1.23 points was observed.
Participants with high program engagement showed greater HbA1c reduction (-1.59%) compared to low engagement (-0.84%).
The results were both clinically and statistically significant (P<.001).

Conclusions:

The Spanish-language Vida Health program improved glycemic control in Spanish-preferring adults.
Higher program engagement correlated with greater improvements in HbA1c.
Digital health interventions can effectively promote glycemic control in medically underserved communities.